212 related articles for article (PubMed ID: 31186199)
1. Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection.
Kleive D; Labori KJ; Line PD; Gladhaug IP; Verbeke CS
HPB (Oxford); 2020 Jan; 22(1):50-57. PubMed ID: 31186199
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.
Han S; Choi DW; Choi SH; Heo JS; Han IW; You YH
Asian J Surg; 2021 Jan; 44(1):313-320. PubMed ID: 32972828
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
4. Pancreaticoduodenectomy with portal vein/superior mesenteric vein resection for patients with pancreatic cancer with venous invasion.
Wang WL; Ye S; Yan S; Shen Y; Zhang M; Wu J; Zheng SS
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):429-35. PubMed ID: 26256089
[TBL] [Abstract][Full Text] [Related]
5. Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.
Delpero JR; Bachellier P; Regenet N; Le Treut YP; Paye F; Carrere N; Sauvanet A; Autret A; Turrini O; Monges-Ranchin G; Boher JM
HPB (Oxford); 2014 Jan; 16(1):20-33. PubMed ID: 23464850
[TBL] [Abstract][Full Text] [Related]
6. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
[TBL] [Abstract][Full Text] [Related]
7. Resection of the Portal-Superior Mesenteric Vein in Pancreatic Cancer: Pathological Assessment and Recurrence Patterns.
Groen JV; van Manen L; van Roessel S; van Dam JL; Bonsing BA; Doukas M; van Eijck CHJ; Farina Sarasqueta A; Putter H; Vahrmeijer AL; Verheij J; Besselink MG; Groot Koerkamp B; Mieog JSD
Pancreas; 2021 Sep; 50(8):1218-1229. PubMed ID: 34714287
[TBL] [Abstract][Full Text] [Related]
8. The impact of extent of pancreatic and venous resection on survival for patients with pancreatic cancer.
Serenari M; Ercolani G; Cucchetti A; Zanello M; Prosperi E; Fallani G; Masetti M; Lombardi R; Cescon M; Jovine E
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):389-394. PubMed ID: 31230959
[TBL] [Abstract][Full Text] [Related]
9. Segmental portal/superior mesenteric vein resection and reconstruction with the iliac vein after pancreatoduodenectomy.
Zhao X; Li LX; Fan H; Kou JT; Li XL; Lang R; He Q
J Int Med Res; 2016 Dec; 44(6):1339-1348. PubMed ID: 28322103
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors after pancreatoduodenectomy with en bloc portal venous resection for pancreatic cancer.
Lapshyn H; Bronsert P; Bolm L; Werner M; Hopt UT; Makowiec F; Wittel UA; Keck T; Wellner UF; Bausch D
Langenbecks Arch Surg; 2016 Feb; 401(1):63-9. PubMed ID: 26739620
[TBL] [Abstract][Full Text] [Related]
12. Postoperative Outcomes of Tangential
Lapshyn H; Schulte T; Petruch N; Petrova E; Honselmann K; Deichmann S; Braun R; Kulemann B; Hoeppner J; Rades D; Keck T; Wellner UF; Bausch D; Bolm L
Anticancer Res; 2021 Oct; 41(10):5123-5130. PubMed ID: 34593463
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.
Yamamoto M; Akamatsu N; Aoki T; Sakamoto Y; Tamura S; Hasegawa K; Kokudo N
Surgery; 2017 Feb; 161(2):385-393. PubMed ID: 27726914
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of resecting the portal vein only when necessary during pancreatoduodenectomy for pancreatic cancer.
Kishi Y; Nara S; Esaki M; Hiraoka N; Shimada K
BJS Open; 2019 Jun; 3(3):327-335. PubMed ID: 31183449
[TBL] [Abstract][Full Text] [Related]
15. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
[TBL] [Abstract][Full Text] [Related]
16. Can post-hoc video review of robotic pancreaticoduodenectomy predict portal/superior mesenteric vein margin status in pancreatic adenocarcinoma?
Jung JP; Zenati MS; Hamad A; Hogg ME; Simmons RL; Zureikat AH; Zeh HJ; Boone BA
HPB (Oxford); 2019 Jun; 21(6):679-686. PubMed ID: 30501987
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic adenocarcinoma with histologically proven portal vein infiltration: what is the outcome?
Martin D; Petermann D; Fontanella S; Pu Y; Halkic N; Demartines N; Schäfer M
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1507-1513. PubMed ID: 30222630
[TBL] [Abstract][Full Text] [Related]
18. Resection of portal and/or superior mesenteric vein and reconstruction by using allogeneic vein for pT3 pancreatic cancer.
Zhang XM; Fan H; Kou JT; Zhang XX; Li P; Dai Y; He Q
J Gastroenterol Hepatol; 2016 Aug; 31(8):1498-503. PubMed ID: 26825612
[TBL] [Abstract][Full Text] [Related]
19. Superior mesenteric-portal vein resection during laparoscopic pancreatoduodenectomy.
Khatkov IE; Izrailov RE; Khisamov AA; Tyutyunnik PS; Fingerhut A
Surg Endosc; 2017 Mar; 31(3):1488-1495. PubMed ID: 27444832
[TBL] [Abstract][Full Text] [Related]
20. Benefit of portal or superior mesenteric vein resection with adjuvant chemotherapy for patients with pancreatic head carcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Nakagawa N; Sueda T
J Surg Oncol; 2013 Mar; 107(4):414-21. PubMed ID: 22886567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
